Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

600 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

NCT02615691

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Kaiser Permanente Oakland M.C. Cupertino, California, United States
  • Kaiser Permanente Oakland M.C. Oakland, California, United States
  • Kaiser Permanente Oakland M.C. Roseville, California, United States
View all 91 locations
View Trial Details
Completed

Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

NCT04091386

Conditions
Behavior, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +8 more
Locations
  • Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders Orange, California, United States
  • Tulane University New Orleans, Louisiana, United States
  • Many Locations Multiple Locations, Belgium
  • Many Locations Multiple Locations, Canada
View Trial Details
Completed

Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects

NCT00868530

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Pfizer Investigational Site Suzhou, Jiangsu, China
  • Pfizer Investigational Site Heping District, Tianjin Municipality, China
  • Pfizer Investigational Site Hangzhou, Zhejiang, China
  • Pfizer Investigational Site Beijing, China
View Trial Details
Completed

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

NCT03938792

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • USF Health Morsani Center For Advanced Healthcare Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • Northwell Health HTC New Hyde Park, New York, United States
  • Washington Institute for Coagulation Seattle, Washington, United States
View all 62 locations
View Trial Details
Completed

A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX Infusions

NCT05437211

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Centre de Reference Hemophilie Unite D'Hemostase Clinique Bron, Auvergne-Rhône-Alpes, France
  • CHU Estaing Clermont-Ferrand, Auvergne-Rhône-Alpes, France
  • Hôpital de Hautepierre - Pôle MIRMED Strasbourg, Grand Est, France
  • CHU Purpan Toulouse, Haute-Garonne, France
View Trial Details
Completed

A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

NCT05707351

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, China
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, China
  • Xiangya Hospital of Central South University Changsha, China
  • Fujian Medical University Union Hospital Fuzhou, China
View Trial Details
Completed

The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B

NCT03623295

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Royal Adelaide Hospital Adelaide, Australia
  • Medical University of Vienna Vienna, Austria
  • Multicentre: Leuven, Brussels Multiple Locations, Belgium
  • Multicentre: Vancouver, Toronto, Hamilton Multiple Locations, Canada
View all 17 locations
View Trial Details
Completed

A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A

NCT04565236

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • The Children's Hospital Zhejiang University School of Med Hangzhou, Hangzhou Province, China
  • Shijiazhuang General Hospital Shijiazhuang, Hebei, China
  • NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School Nanjing, Jiangsu, China
View Trial Details

Related conditions